Literature DB >> 19256582

Diabetic retinopathy: a growing concern in an aging population.

Yannis M Paulus1, Ray F Gariano.   

Abstract

Diabetic retinopathy--already the leading cause of irreversible blindness in working age Americans--is a rising threat as the diabetic population increases. Vision loss occurs due to retinal ischemia, retinal vascular exudation, intraocular hemorrhage, and ultimately, fibrotic complications. Optimal management of blood glucose levels and hypertension reduces the incidence and progression of retinopathy. Appropriate screening ensures early detection and management of diabetic retinopathy and reduces vision loss. Recent advances in our understanding of diabetic microvascular complications have led to new treatments that, along with refinements in laser and surgical techniques, are improving visual outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19256582

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  16 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

2.  Genetic architecture of natural variation in visual senescence in Drosophila.

Authors:  Mary Anna Carbone; Akihiko Yamamoto; Wen Huang; Rachel A Lyman; Tess Brune Meadors; Ryoan Yamamoto; Robert R H Anholt; Trudy F C Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

3.  Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

4.  Primary care physicians' knowledge of the ophthalmic effects of diabetes.

Authors:  Michael N Wiggins; Reid D Landes; Swetangi D Bhaleeya; Sami H Uwaydat
Journal:  Can J Ophthalmol       Date:  2013-08       Impact factor: 1.882

5.  Age-related alterations in retinal neurovascular and inflammatory transcripts.

Authors:  Colleen A Van Kirk; Heather D VanGuilder; Megan Young; Julie A Farley; William E Sonntag; Willard M Freeman
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

6.  Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.

Authors:  Kenichi Kimoto; Toshiaki Kubota
Journal:  J Ophthalmol       Date:  2011-11-03       Impact factor: 1.909

7.  Combination therapy for diabetic macular edema.

Authors:  Dinah Zur; Anat Loewenstein
Journal:  J Ophthalmol       Date:  2012-03-07       Impact factor: 1.909

8.  Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

Authors:  Panshi Yan; Cheng Qian; Wenzhan Wang; Yi Dong; Guangming Wan; Yue Chen
Journal:  Ther Clin Risk Manag       Date:  2016-04-05       Impact factor: 2.423

Review 9.  Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment.

Authors:  Sameer P Leley; Thomas A Ciulla; Ashay D Bhatwadekar
Journal:  Clin Interv Aging       Date:  2021-07-15       Impact factor: 4.458

Review 10.  Diabetic Macular Edema.

Authors:  Fatih C Gundogan; Umit Yolcu; Fahrettin Akay; Abdullah Ilhan; Gokhan Ozge; Salih Uzun
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.